Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TP53BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TMEM234 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLGAP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MARK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHPK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PAAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100233156 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNASEH2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR1236 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAN2B2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC399900 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOP16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01268 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUP62 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSTO2P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF444 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRP36 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on